Invention Grant
- Patent Title: Poxviral oncolytic vectors
-
Application No.: US13778235Application Date: 2013-02-27
-
Publication No.: US09884080B2Publication Date: 2018-02-06
- Inventor: Philippe Erbs , Johann Foloppe
- Applicant: Transgene S.A.
- Applicant Address: unknown Illkirch Graffenstaden
- Assignee: Transgene S.A.
- Current Assignee: Transgene S.A.
- Current Assignee Address: unknown Illkirch Graffenstaden
- Agency: Buchanan Ingersoll & Rooney PC
- Priority: EP07301557 20071119
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A61K39/12 ; A61K39/275 ; A61K45/00 ; A61K35/76 ; C07K14/005 ; C12N7/00 ; C12N15/86 ; A61K38/45 ; A61K38/50 ; A61K35/768 ; A61K31/513
Abstract:
The present invention relates to a poxvirus comprising a defective F4L and/or I4L gene, to composition comprising such poxvirus and to the methods and use of such compositions and poxviruses for therapeutic purposes, and more particularly for the treatment of cancer.
Public/Granted literature
- US20130287737A1 Poxviral Oncolytic Vectors Public/Granted day:2013-10-31
Information query
